Outset Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Outset Medical, Inc. (Nasdaq: OM) announces its participation in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 11:15 am PT / 2:15 pm ET. The company focuses on innovative dialysis technology, specifically the Tablo Hemodialysis System, designed to reduce costs and complexity in dialysis treatments. The Tablo system, FDA cleared for both hospital and home use, allows healthcare providers to deliver dialysis care more efficiently. A live and archived webcast will be available on Outset's Investors webpage.

SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 11:15am PT / 2:15pm ET.

A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221221005004/en/

Jim Mazzola

Vice President, Investor Relations

jmazzola@outsetmedical.com

Brian Johnston

Gilmartin Group

(332) 895-3222

investors@outsetmedical.com

Source: Outset Medical, Inc.

FAQ

When is Outset Medical presenting at the J.P. Morgan Healthcare Conference?

Outset Medical is scheduled to present on Wednesday, January 11, 2023, at 11:15 am PT / 2:15 pm ET.

What technology does Outset Medical focus on?

Outset Medical focuses on innovative dialysis technology, specifically the Tablo Hemodialysis System which simplifies and reduces costs in dialysis treatment.

Where can I find the webcast of Outset Medical's presentation?

A live and archived webcast of Outset Medical's presentation will be available on their Investors webpage at https://investors.outsetmedical.com.

What is the significance of the Tablo Hemodialysis System?

The Tablo Hemodialysis System is significant as it represents a technological advancement in dialysis, allowing treatments to be delivered anytime and anywhere by integrating water purification and on-demand dialysate production.

Is the Tablo Hemodialysis System FDA cleared?

Yes, the Tablo Hemodialysis System is FDA cleared for use from the hospital to the home.